Skip to Content
Merck
All Photos(1)

Key Documents

S4449

Millipore

Seppro® Neutralization Buffer

Synonym(s):

Tris (hydroxymethyl) aminomethane buffer

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41106500
NACRES:
NA.32

compatibility

for use with ABI ViiA 7

Quality Level

storage temp.

2-8°C

General description

Seppro® Neutralization buffer [Tris (hydroxymethyl) aminomethane] is a reagent qualified for use in Seppro® protein preparation and separation systems.

Application

Seppro® neutralization buffer has been used to neutralize the column for immunoglobulin Y (IgY) immunodepletion of top abundant plasma proteins. It has also been used for IgY14 and SuperMix depletion of human plasma.

Legal Information

Seppro is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Simon Sheng et al.
Methods in molecular biology (Clifton, N.J.), 728, 29-46 (2011-04-07)
Serum- and plasma-based biomarker discovery requires technologies with specific capabilities: sufficient proteome coverage and depth, technical reproducibly, and the scalability to enable analysis on a large number of samples at reasonable cost. We have shown that plasma samples processed using
Majlinda Kullolli et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 939, 10-16 (2013-10-05)
Human plasma is a commonly used diagnostic fluid in clinical chemistry. In-depth plasma proteomic analysis is performed to search for disease biomarkers, however the large dynamic range of protein abundance in plasma presents a substantial analytical challenge. Removal of abundant
Hasmik Keshishian et al.
Nature protocols, 12(8), 1683-1701 (2017-07-28)
Proteomic characterization of blood plasma is of central importance to clinical proteomics and particularly to biomarker discovery studies. The vast dynamic range and high complexity of the plasma proteome have, however, proven to be serious challenges and have often led

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service